Polarean Imaging said it has entered into a collaboration with Dutch electrical giant Philips to advance the field of hyperpolarised Xenon MRI.
Philips will showcase its 3T MR 7700 system featuring Polarean's XENOVIEW (xenon Xe 129 hyperpolarised) technology at August’s International Society for Magnetic Resonance in Medicine Annual Meeting & Exhibition in Toronto.
Combining XENOVIEW with Philips MR 7700 multi-nuclei MRI scanner may allow clinicians to view a patient's lungs in greater detail, while also enabling them to accurately measure lung ventilation, Polarean said.
Richard Hullihen, Polarean’s chief executive, commented: "Having attained FDA approval for the first and only hyperpolarized MR contrast agent with the launch of XENOVIEW at the beginning of 2023, we are excited to enter this agreement with Philips.
“By deploying this novel technology to visualize otherwise unobtainable clinical information using MRI technology, MR imaging can now be expanded into pulmonary medicine, providing a quantitative tool to help clinicians and the patients they treat."